Both GPNMB gene expression and protein levels have been shown to be elevated within brain regions of Parkinson’s disease patients, and functional follow-up in these same studies indicated that GPNMB may act through suppression of the inflammatory response [34,35]. This evidence concerns the gene GPNMB and Parkinson disease.